Skip to content

The Peer Assisted Lifestyle Intervention

Testing the Efficacy of a Technology-assisted Intervention to Improve Weight Management of Obese Patients Within Patient Aligned Care Teams at the VA

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03163264
Acronym
PAL
Enrollment
301
Registered
2017-05-23
Start date
2018-01-08
Completion date
2021-12-31
Last updated
2024-11-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obesity, Overweight

Keywords

obesity, weight loss, weight gain, weight management, primary care, health coach

Brief summary

The PAL intervention uses a new software tool delivered on tablets to facilitate 5As-based weight management counseling with a peer health coach and the VA PACT healthcare team to promote goal-setting, behavior change, and weight loss in the primary care (PC) setting. The PAL intervention also includes 10-12 health-coaching calls to the patient over 12 months. As part of a cluster-randomized controlled study, the investigators will randomize 17 primary care providers at the Brooklyn VA to receive either the PAL Intervention or an Enhanced Usual Care control. The primary aim of the study is to explore differences in feasibility, acceptability, and intermediate, behavioral, and weight loss outcomes at 6 and 12 months of 520 patients recruited from the randomized primary care providers. Objective: 1\) Explore the feasibility and impact of this intervention on intermediate, behavioral, and weight loss outcomes at 6 and 12 months post-intervention when compared to enhanced usual care.

Detailed description

Veterans shoulder a disproportionate burden of obesity and its co-morbidities, including diabetes, hypertension, and hyperlipidemia. Modest weight loss in obese patients through diet and exercise improves health and prevents chronic disease, but primary care providers (PCPs) often fail to adequately counsel patients about their weight due to lack of time and training. Thus, tools and brief interventions are needed to support providers' behavior change counseling. The VA currently offers the MOVE! program to treat overweight and obese patients, but only 9% of eligible patients attend. At the same time, Veterans on average see their PCPs 3.6 times per year, which supports the importance of developing primary care (PC)-based interventions. The United States Preventive Services Task force (USPSTF) recommends the use of the 5As framework (Assess, Advise, Agree, Assist, Arrange) for counseling patients about weight. Interactive behavior change technologies utilizing expert system software programs are an innovative way to facilitate 5As counseling to promote behavior change in primary care. These programs perform computerized risk, lifestyle, and theory- based, behavioral assessment to provide computer-generated, tailored advice to patients. They also can provide information to healthcare teams. The MOVE!11 software is an expert system program for VA patients referred to MOVE!, but is not currently used in primary care by Patient-Aligned Care Teams (PACT). Collaborative goal setting can be used to achieve behavior change in this intervention. This construct, a critical component of several behavior change theories and models and corresponding to agree in the 5As model, has been widely recommended for health promotion in primary care. The investigators' formative work (MIRB #01333) using key informant interviews with PACT teamlets and MOVE! staff and focus groups with Veterans demonstrated that goal setting is feasible and acceptable to patients and PACT teamlets and provided insight on barriers to goal setting, and ways to facilitate goal-setting conversations. During the development phase of this project, the investigators developed a primary care-based intervention called MOVE! Toward Your Goals (MTG) to facilitate weight management within primary care and increase adoption of intensive VA programs such as MOVE!. The PAL intervention uses the MTG software tool (that the investigators developed) delivered on tablets to facilitate 5As-based weight management counseling with a health coach and healthcare team to promote goal-setting, behavior change, and weight loss in the primary care setting. The Veteran also receives follow up with 10-12 health coaching calls over 1 year. As part of a clustered randomized control trial, the investigators will randomize 17 primary care providers to either Enhanced Usual Care or the PAL Intervention, recruiting 520 subjects. STUDY OBJECTIVES * Test the impact of the PAL intervention on weight change and behavioral/clinical outcomes * Identify predictors of weight loss in Veterans participating in the intervention group related to goal setting processes and intervention components * Determine the impact of the PAL intervention on obesity-related counseling practices and attitudes

Interventions

BEHAVIORALPeer Assisted Lifestyle

Patients will use PAL online tool accessing weight management and lifestyle behaviors, and will meet with a health coach regularly to establish SMART goals.

BEHAVIORALEnhanced Usual Care

Patients will be given information on healthy living messages that were created by the VA, and given more information on specific messages they are interested in from the health coaches, but will not receive official coaching. These messages are the current standard of care at the VA for obesity counseling.

Sponsors

VA Office of Research and Development
Lead SponsorFED

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
DOUBLE (Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 69 Years
Healthy volunteers
No

Inclusion criteria

* Age 18-69 (this age range represents MOVE! eligibility) * BMI of 30kg/m2 or a BMI of 25kg/m2 with obesity-associated condition * Under the care of PCP with at least 1 prior visit with the provider in the past 24 months * Access to a telephone * Able to travel to Brooklyn VA for in-person evaluations at baseline, 6, and 12 months

Exclusion criteria

* Non-Veterans * A documented current history of active psychosis, active bipolar disorder, or other cognitive issues via ICD-10 codes * Undergoing insulin-therapy for diabetes * Self-reported inability to read at a 5th grade level due to literacy level or vision problems * Has attended more than 4 MOVE! sessions in the past year * Pregnancy * PCP stating that Veteran should not participate

Design outcomes

Primary

MeasureTime frameDescription
Mean Weight Change in Kg12 monthsWeight change in kg at 12 months
Mean Percent Weight Change From Baseline to 12 Months12 monthsMann-Whitney tests for continuous outcomes (e.g., weight change)

Secondary

MeasureTime frameDescription
Changes in Waist Circumference6 monthsTo determine whether patients had changes in waist circumference. Adjusted changes between baseline and 6 Months. Mean (SD) of adjusted outcomes in each treatment arm are provided.
Changes in Physical Activity6 and 12 monthsMeasure duration and intensity using accelerometers. The ActiGraph Link (GT9X) accelerometer, worn on the wrist, was used to objectively measure PA for 7 days at Baseline, and at 6 and 12 months.
Achievement of 5% Weight Loss6 monthsPercent of people in each arm attaining \> or = to 5% weight loss
Percent of People Achieving >150 Minutes of Vigorous to Moderate Physical Activity/Week6 monthsAdjusted mean percent of people achieving behavioral outcome in each treatment arms. Measured duration using IPAQ questionnaire items.
Moderate to Vigorous Physical Activity Difference (Minutes)6 monthsMeasure duration using the Paffenbarger questionnaire items. Difference in adjusted mean behavioral outcome between the treatment arms. Adjusted mean difference (95% Confidence Interval) \[p-value\] between the treatment arms (PAL - EUC) for each behavioral outcome at 6 months of follow-up.
Changes in HB A1C6 and 12 monthsThe investigators will extract HB A1C data from the electronic health record. Due to COVID, participants did not have their regular in-person doctor's appointments to test/collect their HB A1C. Due to a large amount of missing HB A1C data, data was not collected/extracted from the electronic health record and therefore changed in HB A1C was not analyzed.

Countries

United States

Participant flow

Recruitment details

Randomization performed at provider level. Patients recruited from provider panels randomized to each arm (PAL or EUC).

Participants by arm

ArmCount
PAL Intervention: Patients
Body mass index of =30kg/m2 OR Body mass index of =25 kg/m2 with an obesity associated co-morbidity Receiving Peer Assisted Lifestyle intervention (PAL tool, health coaching at baseline, follow-up health coaching calls, potential support of goals from primary care provider) Peer Assisted Lifestyle: Patients will use PAL online tool accessing weight management and lifestyle behaviors, and will meet with a health coach regularly to establish SMART goals.
120
Enhanced Usual Care (EUC): Patients
Body mass index of =30kg/m2 OR Body mass index of =25 kg/m2 with an obesity associated co-morbidity Enhanced Usual Care: Patients will be given information on healthy living messages that were created by the VA, and given more information on specific messages they are interested in from the health coaches, but will not receive official coaching. These messages are the current standard of care at the VA for obesity counseling.
161
PAL Intervention: Providers
Providers at Brooklyn VA with panel size \> 250 Providers received training on the overview of the 5As and the intervention components and practiced brief MI (using role playing) to support Veterans' weight management goals and address barriers to change.
10
Enhanced Usual Care (EUC): Providers
Providers at Brooklyn VA with panel size \> 250 Providers did not receive additional training.
10
Total301

Withdrawals & dropouts

PeriodReasonFG000FG001FG002FG003
Overall StudyDeath0200
Overall StudyLost to Follow-up172000
Overall StudyWithdrawal by Subject13342

Baseline characteristics

CharacteristicEnhanced Usual Care (EUC): PatientsTotalPAL Intervention: PatientsEnhanced Usual Care (EUC): ProvidersPAL Intervention: Providers
Age, Continuous49.9 years
STANDARD_DEVIATION 11.6
50.6 years
STANDARD_DEVIATION 11.5
51.6 years
STANDARD_DEVIATION 11.3
Body Mass Index33.3 kg/m^2
STANDARD_DEVIATION 4.7
33.4 kg/m^2
STANDARD_DEVIATION 5.1
33.5 kg/m^2
STANDARD_DEVIATION 5.6
Diastolic blood pressure77.8 mmHg
STANDARD_DEVIATION 10.5
78.5 mmHg
STANDARD_DEVIATION 19.9
79.3 mmHg
STANDARD_DEVIATION 28
Height173.8 centimeters
STANDARD_DEVIATION 8.5
172.8 centimeters
STANDARD_DEVIATION 8.8
171.5 centimeters
STANDARD_DEVIATION 8.9
Race (NIH/OMB)
American Indian or Alaska Native
3 Participants5 Participants2 Participants
Race (NIH/OMB)
Asian
2 Participants5 Participants3 Participants
Race (NIH/OMB)
Black or African American
97 Participants160 Participants63 Participants
Race (NIH/OMB)
More than one race
5 Participants11 Participants6 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
1 Participants1 Participants0 Participants
Race (NIH/OMB)
Unknown or Not Reported
17 Participants35 Participants18 Participants
Race (NIH/OMB)
White
36 Participants64 Participants28 Participants
Region of Enrollment
United States
161 participants281 participants120 participants
Sex: Female, Male
Female
29 Participants71 Participants31 Participants6 Participants5 Participants
Sex: Female, Male
Male
132 Participants230 Participants89 Participants4 Participants5 Participants
Systolic blood pressure126.9 mmHg
STANDARD_DEVIATION 41.9
125.6 mmHg
STANDARD_DEVIATION 33.1
123.8 mmHg
STANDARD_DEVIATION 14.4
Waist Circumference42.7 inches (in)
STANDARD_DEVIATION 4.7
42.8 inches (in)
STANDARD_DEVIATION 5.4
42.9 inches (in)
STANDARD_DEVIATION 6.2
Weight100.8 kg
STANDARD_DEVIATION 16.3
100.0 kg
STANDARD_DEVIATION 18.2
98.9 kg
STANDARD_DEVIATION 20.4

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
EG002
affected / at risk
EG003
affected / at risk
deaths
Total, all-cause mortality
0 / 1202 / 1610 / 00 / 0
other
Total, other adverse events
36 / 12051 / 1610 / 00 / 0
serious
Total, serious adverse events
14 / 12017 / 1610 / 00 / 0

Outcome results

Primary

Mean Percent Weight Change From Baseline to 12 Months

Mann-Whitney tests for continuous outcomes (e.g., weight change)

Time frame: 12 months

ArmMeasureValue (MEAN)Dispersion
PAL InterventionMean Percent Weight Change From Baseline to 12 Months-2.32 percent changeStandard Deviation 0.75
Enhanced Usual Care (EUC)Mean Percent Weight Change From Baseline to 12 Months-0.69 percent changeStandard Deviation 0.47
p-value: 0.06995% CI: [-0.13, 3.39]Mixed Models Analysis
p-value: 0.02895% CI: [0.21, 3.76]Wilcoxon (Mann-Whitney)
Primary

Mean Weight Change in Kg

Weight change in kg at 12 months

Time frame: 12 months

ArmMeasureValue (MEAN)Dispersion
PAL InterventionMean Weight Change in Kg-2.51 kilograms (kg)Standard Deviation 0.73
Enhanced Usual Care (EUC)Mean Weight Change in Kg-0.79 kilograms (kg)Standard Deviation 0.48
p-value: 0.0595% CI: [0, 3.45]Mixed Models Analysis
p-value: 0.05Wilcoxon (Mann-Whitney)
Secondary

Achievement of 5% Weight Loss

Percent of people in each arm attaining \> or = to 5% weight loss

Time frame: 6 months

ArmMeasureValue (NUMBER)
PAL InterventionAchievement of 5% Weight Loss17 Percent of people
Enhanced Usual Care (EUC)Achievement of 5% Weight Loss6 Percent of people
p-value: 0.03395% CI: [0.92, 21.45]Mixed Models Analysis
Secondary

Achievement of 5% Weight Loss

Percent of people in each arm attaining \> or = to 5% weight loss

Time frame: 12 months

ArmMeasureValue (NUMBER)
PAL InterventionAchievement of 5% Weight Loss26 Percent of people
Enhanced Usual Care (EUC)Achievement of 5% Weight Loss15 Percent of people
p-value: 0.07395% CI: [-1.05, 23.2]Mixed Models Analysis
Secondary

Changes in HB A1C

The investigators will extract HB A1C data from the electronic health record. Due to COVID, participants did not have their regular in-person doctor's appointments to test/collect their HB A1C. Due to a large amount of missing HB A1C data, data was not collected/extracted from the electronic health record and therefore changed in HB A1C was not analyzed.

Time frame: 6 and 12 months

Population: Data were not collected.

Secondary

Changes in Physical Activity

Measure duration and intensity using accelerometers. The ActiGraph Link (GT9X) accelerometer, worn on the wrist, was used to objectively measure PA for 7 days at Baseline, and at 6 and 12 months.

Time frame: 6 and 12 months

Population: The investigators planned to use accelerometers, given out at each study visit, to measure physical activity for 7 days at baseline, 6 month, and 12 months. However, due to COVID-19, the investigators were unable to give out accelerometers at each visit to collect this data. Therefore, data collection was not completed and outcome will not be reported.

Secondary

Changes in Waist Circumference

To determine whether patients had changes in waist circumference. Adjusted changes between baseline and 12 Months. Mean (SD) of adjusted outcomes in each treatment arm are provided.

Time frame: 12 months

ArmMeasureValue (MEAN)Dispersion
PAL InterventionChanges in Waist Circumference-1.82 inches (in)Standard Deviation 0.37
Enhanced Usual Care (EUC)Changes in Waist Circumference-1.40 inches (in)Standard Deviation 0.29
p-value: 0.37895% CI: [-0.52, 1.37]Mixed Models Analysis
Secondary

Changes in Waist Circumference

To determine whether patients had changes in waist circumference. Adjusted changes between baseline and 6 Months. Mean (SD) of adjusted outcomes in each treatment arm are provided.

Time frame: 6 months

ArmMeasureValue (MEAN)Dispersion
PAL InterventionChanges in Waist Circumference-1.44 inches (in)Standard Deviation 0.31
Enhanced Usual Care (EUC)Changes in Waist Circumference-0.72 inches (in)Standard Deviation 0.23
p-value: 0.06595% CI: [-0.05, 1.48]Mixed Models Analysis
Secondary

Moderate to Vigorous Physical Activity Difference (Minutes)

Measure duration using the Paffenbarger questionnaire items. Difference in adjusted mean behavioral outcome between the treatment arms. Adjusted mean difference (95% Confidence Interval) \[p-value\] between the treatment arms (PAL - EUC) for each behavioral outcome at 6 months of follow-up.

Time frame: 6 months

ArmMeasureValue (MEAN)Dispersion
PAL InterventionModerate to Vigorous Physical Activity Difference (Minutes)93.43 minutesStandard Deviation 57.88
Enhanced Usual Care (EUC)Moderate to Vigorous Physical Activity Difference (Minutes)101.78 minutesStandard Deviation 43.96
p-value: 0.91195% CI: [-138.25, 154.95]Mixed Models Analysis
Secondary

Moderate to Vigorous Physical Activity Difference (Minutes)

Measure duration using the Paffenbarger questionnaire items. Difference in adjusted mean behavioral outcome between the treatment arms. Adjusted mean difference (95% Confidence Interval) \[p-value\] between the treatment arms (PAL - EUC) for each behavioral outcome at 12 (primary) months of follow-up.

Time frame: 12 months

ArmMeasureValue (MEAN)Dispersion
PAL InterventionModerate to Vigorous Physical Activity Difference (Minutes)13.32 minutesStandard Deviation 53.77
Enhanced Usual Care (EUC)Moderate to Vigorous Physical Activity Difference (Minutes)46.15 minutesStandard Deviation 45.34
p-value: 0.64895% CI: [-108.15, 173.81]Mixed Models Analysis
Secondary

Percent of People Achieving >150 Minutes of Vigorous to Moderate Physical Activity/Week

Adjusted mean percent of people achieving behavioral outcome in each treatment arms. Measured duration using IPAQ questionnaire items.

Time frame: 6 months

ArmMeasureValue (NUMBER)
PAL InterventionPercent of People Achieving >150 Minutes of Vigorous to Moderate Physical Activity/Week70 percent of people
Enhanced Usual Care (EUC)Percent of People Achieving >150 Minutes of Vigorous to Moderate Physical Activity/Week80 percent of people
p-value: 0.73695% CI: [-49.73, 70.37]Mixed Models Analysis
Secondary

Percent of People Achieving >150 Minutes of Vigorous to Moderate Physical Activity/Week

Adjusted mean percent of people achieving behavioral outcome in each treatment arms. Measured duration using IPAQ questionnaire items.

Time frame: 12 months

ArmMeasureValue (NUMBER)
PAL InterventionPercent of People Achieving >150 Minutes of Vigorous to Moderate Physical Activity/Week29 percent of people
Enhanced Usual Care (EUC)Percent of People Achieving >150 Minutes of Vigorous to Moderate Physical Activity/Week49 percent of people
p-value: 0.5395% CI: [-41.09, 79.8]Mixed Models Analysis

Source: ClinicalTrials.gov · Data processed: Feb 16, 2026